{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:59:45Z","timestamp":1792162785789,"version":"4.4.0"},"reference-count":37,"publisher":"Japan Atherosclerosis Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2021,8,1]]},"DOI":"10.5551\/jat.57703","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T22:09:39Z","timestamp":1601590179000},"page":"844-851","source":"Crossref","is-referenced-by-count":13,"title":["Phenotypic Changes in Macrophage Activation in a Model of Nonalcoholic Fatty Liver Disease using Microminipigs"],"prefix":"10.5551","volume":"28","author":[{"given":"Daiki","family":"Yoshii","sequence":"first","affiliation":[{"name":"Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenobu","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Komohara","sequence":"additional","affiliation":[{"name":"Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University"},{"name":"Center for Metabolic Regulation of Healthy Aging, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Department of Hygiene and Health Promotion Medicine, Kagoshima University Graduate School of Medical and Dental Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohsuke","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Kanazawa Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihide","family":"Tanimoto","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kagoshima University Graduate School of Medical and Dental Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M: Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 2016; 64: 73-84","DOI":"10.1002\/hep.28431"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Arrese M, Cabrera D, Kalergis AM, Feldstein AE: Innate Immunity and Inflammation in NAFLD\/NASH. Dig Dis Sci, 2016; 61: 1294-1303","DOI":"10.1007\/s10620-016-4049-x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Tsuchida T, Friedman SL: Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol, 2017; 14: 397-411","DOI":"10.1038\/nrgastro.2017.38"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Oates JR, McKell MC, Moreno-Fernandez ME, Damen M, Deepe GS, Jr., Qualls JE, Divanovic S: Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack. Front Immunol, 2019; 10:2893","DOI":"10.3389\/fimmu.2019.02893"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Bedossa P: Pathology of non-alcoholic fatty liver disease. Liver Int, 2017; 37 Suppl 1: 85-89","DOI":"10.1111\/liv.13301"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, Srishord M: Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol, 2011; 9: 524-530.e521; quiz e560","DOI":"10.1016\/j.cgh.2011.03.020"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ: Mechanisms of NAFLD development and therapeutic strategies. Nat Med, 2018; 24: 908-922","DOI":"10.1038\/s41591-018-0104-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Komohara Y, Fujiwara Y, Ohnishi K, Shiraishi D, Takeya M: Contribution of Macrophage Polarization to Metabolic Diseases. J Atheroscler Thromb, 2016; 23: 10-17","DOI":"10.5551\/jat.32359"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Tosello-Trampont AC, Landes SG, Nguyen V, Novobrantseva TI, Hahn YS: Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-alpha production. J Biol Chem, 2012; 287: 40161-40172","DOI":"10.1074\/jbc.M112.417014"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Zhang X, Fan L, Wu J, Xu H, Leung WY, Fu K, Wu J, Liu K, Man K, Yang X, Han J, Ren J, Yu J: Macrophage p38alpha promotes nutritional steatohepatitis through M1 polarization. J Hepatol, 2019; 71: 163-174","DOI":"10.1016\/j.jhep.2019.03.014"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Fukushima H, Yamashina S, Arakawa A, Taniguchi G, Aoyama T, Uchiyama A, Kon K, Ikejima K, Watanabe S: Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease. Hepatol Res, 2018; 48: 757-767","DOI":"10.1111\/hepr.13071"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Yamada S, Kawaguchi H, Yamada T, Guo X, Matsuo K, Hamada T, Miura N, Tasaki T, Tanimoto A: Cholic Acid Enhances Visceral Adiposity, Atherosclerosis and Nonalcoholic Fatty Liver Disease in Microminipigs. J Atheroscler Thromb, 2017; 24: 1150-1166","DOI":"10.5551\/jat.39909"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Nakagawa T, Ohnishi K, Kosaki Y, Saito Y, Horlad H, Fujiwara Y, Takeya M, Komohara Y: Optimum immunohistochemical procedures for analysis of macrophages in human and mouse formalin fixed paraffin-embedded tissue samples. J Clin Exp Hematop, 2017; 57: 31-36","DOI":"10.3960\/jslrt.17017"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Fabriek BO, Dijkstra CD, van den Berg TK: The macrophage scavenger receptor CD163. Immunobiology, 2005; 210: 153-160","DOI":"10.1016\/j.imbio.2005.05.010"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kiyanagi T, Iwabuchi K, Shimada K, Hirose K, Miyazaki T, Sumiyoshi K, Iwahara C, Nakayama H, Masuda H, Mokuno H, Sato S, Daida H: Involvement of cholesterol-enriched microdomains in class A scavenger receptor-mediated responses in human macrophages. Atherosclerosis, 2011; 215: 60-69","DOI":"10.1016\/j.atherosclerosis.2010.10.019"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Moore KJ, Freeman MW: Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol, 2006; 26: 1702-1711","DOI":"10.1161\/01.ATV.0000229218.97976.43"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) van Tits LJ, Stienstra R, van Lent PL, Netea MG, Joosten LA, Stalenhoef AF: Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Kr\u00fcppel-like factor 2. Atherosclerosis, 2011; 214: 345-349","DOI":"10.1016\/j.atherosclerosis.2010.11.018"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Goldstein JL, Ho YK, Basu SK, Brown MS: Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A, 1979; 76: 333-337","DOI":"10.1073\/pnas.76.1.333"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kelley JL, Ozment TR, Li C, Schweitzer JB, Williams DL: Scavenger receptor-A (CD204): a two-edged sword in health and disease. Crit Rev Immunol, 2014; 34: 241-261","DOI":"10.1615\/CritRevImmunol.2014010267"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Obstfeld AE, Sugaru E, Thearle M, Francisco AM, Gayet C, Ginsberg HN, Ables EV, Ferrante AW, Jr .: C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis. Diabetes, 2010; 59: 916-925","DOI":"10.2337\/db09-1403"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Holt AP, Haughton EL, Lalor PF, Filer A, Buckley CD, Adams DH: Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver. Gastroenterology, 2009; 136: 705-714","DOI":"10.1053\/j.gastro.2008.10.020"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nunez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, Latz E: NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature, 2010; 464: 1357-1361","DOI":"10.1038\/nature08938"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Colin S, Chinetti-Gbaguidi G, Staels B: Macrophage phenotypes in atherosclerosis. Immunol Rev, 2014; 262: 153-166","DOI":"10.1111\/imr.12218"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Gordon S, Martinez FO: Alternative activation of macrophages: mechanism and functions. Immunity, 2010; 32: 593-604","DOI":"10.1016\/j.immuni.2010.05.007"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Gordon S: Alternative activation of macrophages. Nat Rev Immunol, 2003; 3: 23-35","DOI":"10.1038\/nri978"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Usman A, Ribatti D, Sadat U, Gillard JH: From Lipid Retention to Immune-Mediate Inflammation and Associated Angiogenesis in the Pathogenesis of Atherosclerosis. J Atheroscler Thromb, 2015; 22: 739-749","DOI":"10.5551\/jat.30460"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Khallou-Laschet J, Varthaman A, Fornasa G, Compain C, Gaston AT, Clement M, Dussiot M, Levillain O, Graff-Dubois S, Nicoletti A, Caligiuri G: Macrophage plasticity in experimental atherosclerosis. PLoS One, 2010; 5: e8852","DOI":"10.1371\/journal.pone.0008852"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Ramachandran P, Iredale JP: Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution. J Hepatol, 2012; 56: 1417-1419","DOI":"10.1016\/j.jhep.2011.10.026"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Nati M, Haddad D, Birkenfeld AL, Koch CA, Chavakis T, Chatzigeorgiou A: The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH). Rev Endocr Metab Disord, 2016; 17: 29-39","DOI":"10.1007\/s11154-016-9339-2"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Ilan Y, Shailubhai K, Sanyal A: Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH. Clin Exp Immunol, 2018; 193: 275-283","DOI":"10.1111\/cei.13159"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Van Herck MA, Weyler J, Kwanten WJ, Dirinck EL, De Winter BY, Francque SM, Vonghia L : The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity. Front Immunol, 2019; 10:82","DOI":"10.3389\/fimmu.2019.00082"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Kawaguchi H, Yamada T, Miura N, Ayaori M, Uto-Kondo H, Ikegawa M, Noguchi M, Wang KY, Izumi H, Tanimoto A: Rapid development of atherosclerosis in the world\u2019s smallest Microminipig fed a high-fat\/high-cholesterol diet. J Atheroscler Thromb, 2014; 21: 186-203","DOI":"10.5551\/jat.21246"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR : Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol, 1999; 94: 2467-2474","DOI":"10.1111\/j.1572-0241.1999.01377.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology, 1999; 116: 1413-1419","DOI":"10.1016\/S0016-5085(99)70506-8"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Younossi ZM, Stepanova M, Rafiq N, Makhlouf H, Younoszai Z, Agrawal R, Goodman Z: Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology, 2011; 53: 1874-1882","DOI":"10.1002\/hep.24268"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Allen K, Jaeschke H, Copple BL: Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am J Pathol, 2011; 178: 175-186","DOI":"10.1016\/j.ajpath.2010.11.026"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Sokol RJ, Winklhofer-Roob BM, Devereaux MW, McKim JM, Jr .: Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology, 1995; 109: 1249-1256","DOI":"10.1016\/0016-5085(95)90585-5"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/28\/8\/28_57703\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:38:15Z","timestamp":1715143095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/28\/8\/28_57703\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.57703","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,1]]},"article-number":"57703"}}